An experimental monoclonal antibody has been engineered to target the deadly Nipah virus, an emerging zoonotic pathogen with a human mortality rate ranging as high as a staggering 90%.
Scientists developing a monoclonal antibody to neutralize Nipah virus one of the deadliest zoonotic pathogens
